Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H19NO5 |
Molecular Weight | 317.3365 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(\C=C\C(=O)N2CCC=CC2=O)=CC(OC)=C1OC
InChI
InChIKey=VABYUUZNAVQNPG-BQYQJAHWSA-N
InChI=1S/C17H19NO5/c1-21-13-10-12(11-14(22-2)17(13)23-3)7-8-16(20)18-9-5-4-6-15(18)19/h4,6-8,10-11H,5,9H2,1-3H3/b8-7+
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/25453809Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/29119225 | https://www.ncbi.nlm.nih.gov/pubmed/28011150 | https://www.ncbi.nlm.nih.gov/pubmed/28673967
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25453809
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/29119225 | https://www.ncbi.nlm.nih.gov/pubmed/28011150 | https://www.ncbi.nlm.nih.gov/pubmed/28673967
Piperlongumine is a natural bioactive small molecule isolated from the Piper longum Linn plant. This compound is easily available, inexpensive, and has therapeutic effects against cancer, heart disease, intestinal diseases, diabetes, obesity, joint pain and other conditions in Chinese Herbal and Indian Ayurvedic medicine. As a primary constituent of Piper longum Linn, PLM has been reported to exert effects against cancer, platelet aggregation, atherosclerosis, diabetes and inflammation. Mechanistic investigations have found that PLM selectively augments ROS levels in tumor cells and regulates downstream signaling, including NF-κB, MAPK, and STAT3 pathways, in several other cell types.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: WP3544 Sources: https://www.ncbi.nlm.nih.gov/pubmed/29109039 |
|||
Target ID: WP3617 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28011150 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29119225
Synovial tissues were obtained from patients with active RA (6 females and 1 male, aged 45–67 years) who were undergoing synovectomy or joint replacement. RA FLS were cultured in serum-free DMEM/F12 for 24 h at a density of 1 Ч 104 cells/well in 96-well plates in triplicate. After starvation, the cells were untreated (as negative control) or treated with 0.1% dimethyl sulfoxide (DMSO) (#D2650, Sigma, USA) or various concentrations of PLM (Piperlongumine) (5, 10, 15, 20 μM) for 48 h in DMEM/F12 with 10% FBS. After this period, the cells were cultured in FBS-free DMEM/F12 for 12 h. Ten microliters 5% MTT (dissolved in PBS, PH 7.4, Sigma, USA) was added to the cells, which were incubated for 4–6 h. The cells were washed twice with PBS, followed by the addition of 100 μl DMSO. The cells were shaken gently for 10 min at 37 °C to achieve complete dissolution. The absorbances were read on a spectrophotometer at wavelengths of 570 and 620 nm.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
PIPERLONGUMINE
Created by
admin on Fri Dec 15 18:09:31 GMT 2023 , Edited by admin on Fri Dec 15 18:09:31 GMT 2023
|
PRIMARY | |||
|
20069-09-4
Created by
admin on Fri Dec 15 18:09:31 GMT 2023 , Edited by admin on Fri Dec 15 18:09:31 GMT 2023
|
PRIMARY | |||
|
m8856
Created by
admin on Fri Dec 15 18:09:31 GMT 2023 , Edited by admin on Fri Dec 15 18:09:31 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID801029762
Created by
admin on Fri Dec 15 18:09:31 GMT 2023 , Edited by admin on Fri Dec 15 18:09:31 GMT 2023
|
PRIMARY | |||
|
637858
Created by
admin on Fri Dec 15 18:09:31 GMT 2023 , Edited by admin on Fri Dec 15 18:09:31 GMT 2023
|
PRIMARY | |||
|
SGD66V4SVJ
Created by
admin on Fri Dec 15 18:09:31 GMT 2023 , Edited by admin on Fri Dec 15 18:09:31 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD